AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

11.12

-1.15 (-9.37%)

At close: Nov 2, 2026, 4:00 PM EST

11.18

+0.06 (0.54%)

After-hours: Nov 2, 2026, 7:55 PM EST

AbCellera Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,603	1,024	865	1,657	2,898	4,027
Market Cap Growth	117.27%	18.29%	-47.77%	-42.83%	-28.02%	-62.83%
Enterprise Value	3,199	670	294	952	2,106	3,305
Last Close Price	11.12	3.42	2.93	5.71	10.13	14.30

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	18.28	26.24
Forward PE	-	60.15	60.15	60.15	60.15	51.81
PS Ratio	54.46	13.63	30.02	43.57	5.97	10.73
PB Ratio	3.80	1.06	0.82	1.44	2.35	3.93
P/TBV Ratio	4.44	1.16	0.90	1.68	2.75	4.85
P/FCF Ratio	-	-	-	-	14.02	21.63
P/OCF Ratio	-	-	-	-	10.45	16.46
PEG Ratio	-	15.04	15.04	15.04	15.04	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	48.34	8.92	10.19	25.03	4.34	8.81
EV/EBITDA Ratio	-	-	-	-	8.62	15.10
EV/EBIT Ratio	-	-	-	-	9.36	16.17
EV/FCF Ratio	-	-	-	-	10.19	17.76

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.15	0.15	0.06	0.07	0.07	0.04
Debt / EBITDA Ratio	-	-	-	-	0.32	0.18
Debt / FCF Ratio	-	-	-	-	0.40	0.22
Net Debt / Equity Ratio	-0.45	-0.40	-0.53	-0.59	-0.65	-0.67
Net Debt / EBITDA Ratio	2.02	2.00	2.50	3.21	-3.29	-3.12
Net Debt / FCF Ratio	3.38	2.24	3.00	5.66	-3.89	-3.67
Asset Turnover	0.05	0.06	0.02	0.03	0.34	0.32
Inventory Turnover	-	-	-	-	108.81	69.86
Quick Ratio	11.23	10.07	8.95	6.93	8.37	7.44
Current Ratio	12.77	11.32	9.81	7.33	8.67	7.71
Return on Equity (ROE)	-17.30%	-14.47%	-14.75%	-12.27%	14.03%	16.54%
Return on Assets (ROA)	-10.39%	-9.99%	-12.41%	-9.79%	9.83%	10.99%
Return on Invested Capital (ROIC)	-42.28%	-40.50%	-58.61%	-52.82%	38.64%	49.05%
Return on Capital Employed (ROCE)	-17.90%	-16.80%	-22.00%	-17.30%	15.80%	17.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-4.91%	-14.30%	-18.82%	-8.84%	5.47%	3.81%
FCF Yield	-3.32%	-17.00%	-21.60%	-7.29%	7.13%	4.62%
Buyback Yield / Dilution	-1.74%	-1.49%	-1.79%	8.15%	1.09%	-20.96%

SEC Filings: 10-K · 10-Q